Actinium Pharmaceuticals
ATNM
#9640
Rank
NZ$66.39 M
Marketcap
$2.13
Share price
0.00%
Change (1 day)
-82.10%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -NZ$69.63 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -NZ$87.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$70.6 Million-18.87%
2023 -NZ$87.02 Million52.24%
2022 -NZ$57.16 Million36.61%
2021 -NZ$41.84 Million11.48%
2020 -NZ$37.53 Million1.46%
2019 -NZ$36.99 Million-7.37%
2018 -NZ$39.94 Million-11.46%
2017 -NZ$45.1 Million10.67%
2016 -NZ$40.76 Million15.7%
2015 -NZ$35.23 Million-14.86%
2014 -NZ$41.38 Million129.19%
2013 -NZ$18.06 Million-8.55%
2012 -NZ$19.74 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$62.33 Million-11.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B-1,386.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$48.2 Million-31.73%๐Ÿ‡บ๐Ÿ‡ธ USA